Information
News News
- Information
Article on Joint Research Agreement Between Elix and Axcelead DDP on Targeted Protein Degraders Featured in Daily Yakugyo
- News Release
Elix and Axcelead DDP Enter into Collaborative Research Agreement to Advance Targeted Protein Degrader Discovery: Combining AI Drug Discovery Technologies with Drug Discovery Expertise to Advance Solutions for Challenging Targets
- Information
Article on Joint Research with University of Vienna Using AI and NMR Featured in Nikkei Biotech ONLINE
MedChem’s ultimate partner for AI drug discovery,
from predictive and generative models with an intuitive UI to expert consulting, all in a single package.
Data Advantage:
16 Pharma Partners
AI models trained on proprietary data from 16 pharma partners, covering activity, ADME, and toxicity.
Novel Structures
Beyond Human ImaginationDesigns novel, non-obvious structures, proven across multiple programs.
PhD-Led Consulting & Support
Experienced PhD scientists provide hands-on onboarding, workflow integration, and ongoing support.
Partners
Our Clients and Partners
We are collaborating with pharmaceutical companies, academic institutes, and drug discovery start-ups.
